IP Library Granted Patent US 9,814,616
Granted Patent B2
US 9,814,616 · App. 15/620,529 · Granted Nov 14, 2017

Methods of and devices for chemical and threshold-gated electrical neuro-immuno-stimulation

Inventor: Charles C. Koo (Palo Alto, CA)
A61F5/02A61F5/013A61K31/165A61K38/18A61K38/1833A61K38/191A61N1/36021A61N1/36042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,814,616
App. No.
15/620,529
Granted
Nov 14, 2017
Kind
B2
Abstract

A method of reducing pain and induce/enhance the stem cell growth/differentiation reaction includes identifying a pair of related Noxipoints on an identified muscle/organ and applying a chemical/electrical stimulation to the pair of Noxipoints.

Claims (29)

1. An electrical treatment device comprising:

a) a guiding device configured to guide a user to identify a pair of Noxipoints, wherein the pair of Noxipoints are located at two terminal ends of an organ; and

b) an electrical control circuit configured to tune an applied electrical stimulation, such that a predetermined electrical power is applied to the pair of Noxipoints.

2. The device of claim 1 , wherein the electrical control circuit is configured to adjust a pulse pattern applied to the Noxipoints.

3. The device of claim 1 , wherein the electrical control circuit is configured to adjust a pulse duration applied to the Noxipoints.

4. The device of claim 1 , wherein the electrical control circuit is configured to adjust a pulse strength applied to the Noxipoints.

5. The device of claim 1 , wherein the electrical control circuit is configured to generate an anatomic site specific stimulation.

6. The device of claim 1 , wherein the electrical control circuit is configured to generate an intensity and submodality specific stimulation.

7. The device of claim 6 , wherein the submodality comprises a moderate soreness, an achiness or a mild dull pain.

8. The device of claim 1 , wherein the organ comprises a muscle tissue.

9. The device of claim 1 , wherein the electrical control circuit is configured to triggers a reaction of a neuroimmune cascade at the pair of Noxipoints.

10. The device of claim 1 , further comprising a user interface configured to adjust an electrical stimulation at the pair of Noxipoints.

11. An electrical treatment device comprising:

a) a user controlling device containing a user control panel; and

b) an electrical control circuit configured to adjust an applied electrical stimulation based on an input received at the user controlling device, such that a predetermined electrical power is applied to the pair of Noxipoints.

12. The device of claim 11 , wherein the electrical control circuit is configured to adjust a pulse pattern applied to the Noxipoints.

13. The device of claim 11 , wherein the electrical control circuit is configured to adjust a pulse duration applied to the Noxipoints.

14. The device of claim 11 , wherein the electrical control circuit is configured to adjust a pulse strength applied to the Noxipoints.

15. A treatment device comprising:

a) a user-interface control panel configured to control and to receive an input of a response of an applied stimulation that is applied to a pair of Noxipoints; and

b) a control circuit configured to tune the applied stimulation based on the input of the response.

16. The device of claim 15 , wherein the response comprises a user's perceived sensation of a soreness, an achiness, a dull pain, a sharp pain or a combination thereof.

17. The device of claim 15 , wherein the control circuit or a software control is configured to continue increasing an applied voltage when an input/response is not a sensation of a soreness, an achiness, a dull pain, a deep pins-and-needles sharp pain or a combination thereof.

18. The device of claim 15 , further comprising a software system indicating or identifying a location of a corresponding Noxipoint of the pair of Noxipoints.

19. The device of claim 18 , wherein the software system comprising a 3-dimensional modeling of a human anatomy and an indication of pairs of Noxipoints corresponding to an injured organ.

20. The device of claim 15 , wherein the treatment device is a part of or imbedded in a helmet, a hat, a cervical brace, a shoulder support, a wrist brace, a back brace, a vest, a skin-tight ware, a footware or wheel chairs.

21. The device of claim 15 , wherein the stimulation comprises an electrical, a chemical stimulation, or a combination thereof.

22. The device of claim 21 , wherein the stimulation is laid out as a grid of alternating electrodes.

23. The device of claim 15 , wherein the stimulation comprises an infrared light stimulation, an ultrasound stimulation, a laser beam stimulation, or a combination thereof.

Continuity (4)
Continuation 14631781 · Feb 25, 2015
Continuation In Part 13396605 · Feb 15, 2012
Provisional Application 61443258 · Feb 16, 2011
Related Publication 20170273816A1 · Sep 28, 2017